Kristen A Eckert1, Marissa J Carter1, Van C Lansingh2, David A Wilson3, João M Furtado4, Kevin D Frick5, Serge Resnikoff3. 1. a Strategic Solutions, Inc. , Cody , WY , USA . 2. b International Agency for the Prevention of Blindness (IAPB) Latin America , Queretaro , Mexico . 3. c Brien Holden Vision Institute (BHVI), University of New South Wales , Sydney , New South Wales , Australia . 4. d Department of Ophthalmology , Otorhinolaryngology, and Head and Neck Surgery, School of Medicine of Ribeirão Preto, University of São Paulo , Ribeirão Preto , São Paulo , Brazil , and. 5. e Johns Hopkins Carey Business School , Baltimore , MD , USA.
Abstract
PURPOSE: To estimate the annual loss of productivity from blindness and moderate to severe visual impairment (MSVI) using simple models (analogous to how a rapid assessment model relates to a comprehensive model) based on minimum wage (MW) and gross national income (GNI) per capita (US$, 2011). METHODS: Cost of blindness (COB) was calculated for the age group ≥50 years in nine sample countries by assuming the loss of current MW and loss of GNI per capita. It was assumed that all individuals work until 65 years old and that half of visual impairment prevalent in the ≥50 years age group is prevalent in the 50-64 years age group. For cost of MSVI (COMSVI), individual wage and GNI loss of 30% was assumed. Results were compared with the values of the uncorrected refractive error (URE) model of productivity loss. RESULTS: COB (MW method) ranged from $0.1 billion in Honduras to $2.5 billion in the United States, and COMSVI ranged from $0.1 billion in Honduras to $5.3 billion in the US. COB (GNI method) ranged from $0.1 million in Honduras to $7.8 billion in the US, and COMSVI ranged from $0.1 billion in Honduras to $16.5 billion in the US. Most GNI method values were near equivalent to those of the URE model. CONCLUSION: Although most people with blindness and MSVI live in developing countries, the highest productivity losses are in high income countries. The global economy could improve if eye care were made more accessible and more affordable to all.
PURPOSE: To estimate the annual loss of productivity from blindness and moderate to severe visual impairment (MSVI) using simple models (analogous to how a rapid assessment model relates to a comprehensive model) based on minimum wage (MW) and gross national income (GNI) per capita (US$, 2011). METHODS: Cost of blindness (COB) was calculated for the age group ≥50 years in nine sample countries by assuming the loss of current MW and loss of GNI per capita. It was assumed that all individuals work until 65 years old and that half of visual impairment prevalent in the ≥50 years age group is prevalent in the 50-64 years age group. For cost of MSVI (COMSVI), individual wage and GNI loss of 30% was assumed. Results were compared with the values of the uncorrected refractive error (URE) model of productivity loss. RESULTS: COB (MW method) ranged from $0.1 billion in Honduras to $2.5 billion in the United States, and COMSVI ranged from $0.1 billion in Honduras to $5.3 billion in the US. COB (GNI method) ranged from $0.1 million in Honduras to $7.8 billion in the US, and COMSVI ranged from $0.1 billion in Honduras to $16.5 billion in the US. Most GNI method values were near equivalent to those of the URE model. CONCLUSION: Although most people with blindness and MSVI live in developing countries, the highest productivity losses are in high income countries. The global economy could improve if eye care were made more accessible and more affordable to all.
Authors: Kay D Beharry; Charles L Cai; Faisal Siddiqui; Sara Chowdhury; Christina D'Agrosa; Gloria B Valencia; Jacob V Aranda Journal: Antioxidants (Basel) Date: 2018-11-09
Authors: Xiaotong Han; Jane Scheetz; Stuart Keel; Chimei Liao; Chi Liu; Yu Jiang; Andreas Müller; Wei Meng; Mingguang He Journal: Transl Vis Sci Technol Date: 2019-08-19 Impact factor: 3.283
Authors: Ana Patricia Marques; Jacqueline Ramke; John Cairns; Thomas Butt; Justine H Zhang; Debbie Muirhead; Iain Jones; Brandon A M Ah Tong; Bonnielin K Swenor; Hannah Faal; Rupert R A Bourne; Kevin D Frick; Matthew J Burton Journal: EClinicalMedicine Date: 2021-04-26
Authors: Kay D Beharry; Charles L Cai; Jacqueline Skelton; Faisal Siddiqui; Christina D'Agrosa; Johanna Calo; Gloria B Valencia; Jacob V Aranda Journal: Int J Mol Sci Date: 2018-05-01 Impact factor: 5.923
Authors: Ana Patricia Marques; Jacqueline Ramke; John Cairns; Thomas Butt; Justine H Zhang; Hannah B Faal; Hugh Taylor; Iain Jones; Nathan Congdon; Andrew Bastawrous; Tasanee Braithwaite; Marty Jovic; Serge Resnikoff; Allyala Nandakumar; Peng Tee Khaw; Rupert R A Bourne; Iris Gordon; Kevin Frick; Matthew J Burton Journal: BMJ Open Date: 2020-09-06 Impact factor: 2.692